ATE455302T1 - Komplexformierungs- und -trennungsverfahren - Google Patents

Komplexformierungs- und -trennungsverfahren

Info

Publication number
ATE455302T1
ATE455302T1 AT06802235T AT06802235T ATE455302T1 AT E455302 T1 ATE455302 T1 AT E455302T1 AT 06802235 T AT06802235 T AT 06802235T AT 06802235 T AT06802235 T AT 06802235T AT E455302 T1 ATE455302 T1 AT E455302T1
Authority
AT
Austria
Prior art keywords
complex
analyte
analog
separation process
complex forming
Prior art date
Application number
AT06802235T
Other languages
English (en)
Inventor
Tomohisa Kawabata
Shinji Satomura
Henry Wada
Original Assignee
Wako Pure Chem Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wako Pure Chem Ind Ltd filed Critical Wako Pure Chem Ind Ltd
Application granted granted Critical
Publication of ATE455302T1 publication Critical patent/ATE455302T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/561—Immunoelectrophoresis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/02—Form or structure of the vessel
    • C12M23/16—Microfluidic devices; Capillary tubes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M45/00—Means for pre-treatment of biological substances
    • C12M45/07—Means for pre-treatment of biological substances by electrical or electromagnetic forces
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/5375—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by changing the physical or chemical properties of the medium or immunochemicals, e.g. temperature, density, pH, partitioning
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/30—Detection of binding sites or motifs
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/50—Mutagenesis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/10—Analysis or design of chemical reactions, syntheses or processes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/701—Integrated with dissimilar structures on a common substrate
    • Y10S977/702—Integrated with dissimilar structures on a common substrate having biological material component
    • Y10S977/705—Protein or peptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Sustainable Development (AREA)
  • General Engineering & Computer Science (AREA)
  • Electrochemistry (AREA)
  • Computing Systems (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Clinical Laboratory Science (AREA)
AT06802235T 2005-09-02 2006-08-24 Komplexformierungs- und -trennungsverfahren ATE455302T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71334605P 2005-09-02 2005-09-02
PCT/US2006/033043 WO2007027495A1 (en) 2005-09-02 2006-08-24 Complex formation method and separation method

Publications (1)

Publication Number Publication Date
ATE455302T1 true ATE455302T1 (de) 2010-01-15

Family

ID=37507817

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06802235T ATE455302T1 (de) 2005-09-02 2006-08-24 Komplexformierungs- und -trennungsverfahren

Country Status (9)

Country Link
US (1) US9429572B2 (de)
EP (1) EP1920255B1 (de)
JP (1) JP5257072B2 (de)
CN (1) CN101300488B (de)
AT (1) ATE455302T1 (de)
CA (1) CA2620403A1 (de)
DE (1) DE602006011756D1 (de)
ES (1) ES2338256T3 (de)
WO (1) WO2007027495A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007027495A1 (en) * 2005-09-02 2007-03-08 Wako Pure Chemical Industries, Ltd Complex formation method and separation method
KR100858078B1 (ko) * 2006-10-04 2008-09-10 삼성에스디아이 주식회사 프로톤 전도성기가 결합된 무기 나노입자 및 고체산을포함하는 고분자 전해질막 및 그 제조방법
JP5397229B2 (ja) 2008-02-22 2014-01-22 和光純薬工業株式会社 β−グルカン及び／又はエンドトキシン測定用基質並びに測定方法
ES2655725T3 (es) 2009-03-17 2018-02-21 Wako Pure Chemical Industries, Ltd. Método para medir beta-glucano, y proteína de unión a beta-glucano para su uso en el método
US8580097B2 (en) * 2009-04-27 2013-11-12 Wako Pure Chemical Industries, Ltd. Isotachophoresis of blood-derived samples
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
EP2774994B1 (de) 2011-11-01 2016-12-07 National Institute of Advanced Industrial Science and Technology Undifferenziertes zelldetektionsverfahren und komplexes kohlenhydratdetektionsverfahren
AU2013236175A1 (en) 2012-03-22 2014-10-16 Kanagawa Prefectural Hospital Organization Method for identification and detection of mutant gene using intercalator
US20150050649A1 (en) 2012-03-22 2015-02-19 Wako Pure Chemical Industries, Ltd. Method for detecting dna having microsatellite region
JP6664872B2 (ja) 2014-10-28 2020-03-13 株式会社Gbs 充電装置、充電プログラム、充電方法
CA3005430A1 (en) 2015-11-16 2017-05-26 Revere Biosensors, Llc Systems and methods for identifying and distinguishing genetic samples
WO2017130578A1 (ja) 2016-01-27 2017-08-03 和光純薬工業株式会社 前立腺癌の判定方法
KR102259445B1 (ko) 2016-03-30 2021-06-01 후지필름 와코 준야쿠 가부시키가이샤 클라미디아 트라코마티스 검출용 프라이머 세트 및 이것을 사용한 클라미디아 트라코마티스 검출 방법, 그리고 그것을 위한 시약 키트
JPWO2018174044A1 (ja) * 2017-03-22 2020-01-23 富士フイルム和光純薬株式会社 糖鎖を有する物質とレクチンとの複合体形成方法
CN110869512A (zh) * 2017-05-09 2020-03-06 雷瑞生物传感器有限责任公司 鉴别并区分遗传样品的系统及方法
EP3796001B1 (de) 2018-05-18 2023-08-09 FUJIFILM Corporation Verfahren zur bestimmung von prostatakarzinomen
WO2020045342A1 (ja) * 2018-08-28 2020-03-05 国立大学法人東京大学 前処理試薬、並びに、ナノ粒子の分析及び回収方法
EP3931353A4 (de) 2019-03-01 2022-11-16 Revere Biosensors, LLC Systeme und verfahren zur trennung von decodierten arrays
US20220298586A1 (en) 2019-08-23 2022-09-22 Fujifilm Wako Pure Chemical Corporation Primer pair for detecting pneumocystis jirovecii, method for detecting pneumocystis jirovecii using same and reagent kit therefor
WO2021124960A1 (ja) 2019-12-18 2021-06-24 富士フイルム和光純薬株式会社 マイコバクテリウム・ツベルクローシス、マイコバクテリウム・アビウム及びマイコバクテリウム・イントラセルラーを検出するためのプライマーセット及びこれを用いた方法、並びにそのための試薬キット
EP4187246A4 (de) 2020-07-22 2024-02-07 FUJIFILM Corporation Verfahren zur unterstützung der diagnose von entzündlicher darmerkrankung

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0103965A2 (de) * 1982-08-20 1984-03-28 Imperial Chemical Industries Plc Elektrofokussierapparat
JPH08501392A (ja) * 1992-09-14 1996-02-13 パーデュー リサーチ ファウンデーション 電気泳動法による化学分析
US5958202A (en) * 1992-09-14 1999-09-28 Perseptive Biosystems, Inc. Capillary electrophoresis enzyme immunoassay
US5348633A (en) * 1993-01-22 1994-09-20 Northeastern University Method for quantitating trace amounts of an analyte in a sample by affinity capillary electrophoresis
US6001229A (en) * 1994-08-01 1999-12-14 Lockheed Martin Energy Systems, Inc. Apparatus and method for performing microfluidic manipulations for chemical analysis
DE60236262D1 (de) * 2001-04-04 2010-06-17 Wako Pure Chem Ind Ltd Elektrophorese mit doppelstrang-dna-marker
AU2003257040A1 (en) * 2002-07-29 2004-02-16 David P. Dumas Transparent polymer support for electrophoresis and electrochromatography and related methods
US7672786B2 (en) * 2003-07-02 2010-03-02 Sergey Krylov Non-equilibrium capillary electrophoresis of equilibrium mixtures (NECEEM)—based methods for drug and diagnostic development
FR2862134B1 (fr) * 2003-11-12 2007-07-27 Sebia Sa Analyse et typage de proteines monoclonales par electrophorese capillaire et immunodeplacement
CN100342229C (zh) * 2004-12-27 2007-10-10 山东大学 蛋白酶解物的血管紧张素转化酶抑制活性的快速测定技术
WO2007027495A1 (en) * 2005-09-02 2007-03-08 Wako Pure Chemical Industries, Ltd Complex formation method and separation method

Also Published As

Publication number Publication date
JP5257072B2 (ja) 2013-08-07
CN101300488B (zh) 2012-09-05
WO2007027495A1 (en) 2007-03-08
EP1920255A1 (de) 2008-05-14
CA2620403A1 (en) 2007-03-08
JP2009507223A (ja) 2009-02-19
DE602006011756D1 (de) 2010-03-04
ES2338256T3 (es) 2010-05-05
EP1920255B1 (de) 2010-01-13
US9429572B2 (en) 2016-08-30
US20090152114A1 (en) 2009-06-18
CN101300488A (zh) 2008-11-05

Similar Documents

Publication Publication Date Title
DE602006011756D1 (de) Komplexformierungs- und -trennungsverfahren
EP4414690A3 (de) Biosensoren zur biologischen oder chemischen analyse und verfahren zur herstellung davon
WO2008130376A3 (en) Determination of explosives including rdx
ECSP088081A (es) Detección de un antigeno diana independientemente de la presencia o ausencia de un anticuerpo terapéutico correspondiente
EP2419733A4 (de) Verfahren und vorrichtungen zur erkennung des vorhandenseins eines analyts in einer probe
DK2132339T3 (da) Fremgangsmåde til detektering af en analyt i en biologisk matrix
EA201390638A1 (ru) Обогащение и идентификация фетальных клеток в материнской крови и лиганды для такого применения
WO2007002579A3 (en) Assay cartridges and methods for point of care instruments
ATE538715T1 (de) System zur in vivo analyse
BRPI0610092B8 (pt) métodos para a detecção de um analito e de um ácido nucleico em uma amostra, e de sintetização de uma molécula de ácido nucleico ou de análogo de ácido nucleico, kit reagente, uso do mesmo, molécula de ácido nucleico ou de análogo de ácido nucleico e produto associado
ATE505729T1 (de) System zur erkennung und quantifizierung biologischer materie aus einem oder mehreren optischen sensoren und einer oder mehreren lichtquellen, entsprechendes verfahren und anwendungen dafür
MX369610B (es) Metodos, dispositivos y sistemas para analisis de muestras.
MX2009013009A (es) Inmunoensayos de alta sensibilidad y kits para la determinacion de peptidos y proteinas de interes biologico.
MX2013011768A (es) Dispositivo analitico.
ATE551055T1 (de) Nachweis von succinylaceton
DE60315715D1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
DK1989544T3 (da) T-celle-testmetode
WO2019135800A3 (en) Purification and detection of analytes
EA030186B9 (ru) Способ проведения количественных анализов
WO2007029164A3 (en) Nitric oxide detection
GB201017256D0 (en) Sensor and method
WO2002099381A3 (en) A single-cell biosensor for the measurement of gpcr ligands in a test sample
WO2011088423A3 (en) Isobaric tags for analyte detection and quantification
WO2020264444A3 (en) Assay method for point of care quantification of an immunophilin-binding immunosuppressant drug
GB201113814D0 (en) Materials and methods for determining sensitivity potential of compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties